Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary

In the following, we report a therapeutic challenge faced by reduction in corticosteroid therapeutic dosage in a patient diagnosed with Hashimoto's encephalopathy (HE), which is equivalent to corticosteroid‐responsive encephalopathy related to autoimmune thyroiditis and often misdiagnosed as ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidaki, Reza, Saghafi, Fatemeh, Ahrari, Samira, Aghamollaii, Vajiheh, Rahmani, Mojde, Asadi, Ahdie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710709/
https://www.ncbi.nlm.nih.gov/pubmed/34963799
http://dx.doi.org/10.1002/ccr3.5081
_version_ 1784623218631376896
author Bidaki, Reza
Saghafi, Fatemeh
Ahrari, Samira
Aghamollaii, Vajiheh
Rahmani, Mojde
Asadi, Ahdie
author_facet Bidaki, Reza
Saghafi, Fatemeh
Ahrari, Samira
Aghamollaii, Vajiheh
Rahmani, Mojde
Asadi, Ahdie
author_sort Bidaki, Reza
collection PubMed
description In the following, we report a therapeutic challenge faced by reduction in corticosteroid therapeutic dosage in a patient diagnosed with Hashimoto's encephalopathy (HE), which is equivalent to corticosteroid‐responsive encephalopathy related to autoimmune thyroiditis and often misdiagnosed as neuropsychiatric status. The patient developed psychiatric symptoms.
format Online
Article
Text
id pubmed-8710709
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87107092021-12-27 Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary Bidaki, Reza Saghafi, Fatemeh Ahrari, Samira Aghamollaii, Vajiheh Rahmani, Mojde Asadi, Ahdie Clin Case Rep Case Report In the following, we report a therapeutic challenge faced by reduction in corticosteroid therapeutic dosage in a patient diagnosed with Hashimoto's encephalopathy (HE), which is equivalent to corticosteroid‐responsive encephalopathy related to autoimmune thyroiditis and often misdiagnosed as neuropsychiatric status. The patient developed psychiatric symptoms. John Wiley and Sons Inc. 2021-12-26 /pmc/articles/PMC8710709/ /pubmed/34963799 http://dx.doi.org/10.1002/ccr3.5081 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Bidaki, Reza
Saghafi, Fatemeh
Ahrari, Samira
Aghamollaii, Vajiheh
Rahmani, Mojde
Asadi, Ahdie
Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary
title Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary
title_full Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary
title_fullStr Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary
title_full_unstemmed Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary
title_short Challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: A running commentary
title_sort challenges in corticosteroid dose regulation in a patient with autoimmune thyroid disease and neuropsychiatric syndrome: a running commentary
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710709/
https://www.ncbi.nlm.nih.gov/pubmed/34963799
http://dx.doi.org/10.1002/ccr3.5081
work_keys_str_mv AT bidakireza challengesincorticosteroiddoseregulationinapatientwithautoimmunethyroiddiseaseandneuropsychiatricsyndromearunningcommentary
AT saghafifatemeh challengesincorticosteroiddoseregulationinapatientwithautoimmunethyroiddiseaseandneuropsychiatricsyndromearunningcommentary
AT ahrarisamira challengesincorticosteroiddoseregulationinapatientwithautoimmunethyroiddiseaseandneuropsychiatricsyndromearunningcommentary
AT aghamollaiivajiheh challengesincorticosteroiddoseregulationinapatientwithautoimmunethyroiddiseaseandneuropsychiatricsyndromearunningcommentary
AT rahmanimojde challengesincorticosteroiddoseregulationinapatientwithautoimmunethyroiddiseaseandneuropsychiatricsyndromearunningcommentary
AT asadiahdie challengesincorticosteroiddoseregulationinapatientwithautoimmunethyroiddiseaseandneuropsychiatricsyndromearunningcommentary

Ejemplares similares